2 false false false false false false false false false false true false false false false false false No description of principal activity 2024-04-01 Sage Accounts Production Advanced 2024 - FRS102_2024 400,000 130,000 40,000 170,000 230,000 270,000 xbrli:pure xbrli:shares iso4217:GBP 12693636 2024-04-01 2025-03-31 12693636 2025-03-31 12693636 2024-03-31 12693636 2023-04-01 2024-03-31 12693636 2024-03-31 12693636 2023-03-31 12693636 bus:Director1 2024-04-01 2025-03-31 12693636 core:WithinOneYear 2025-03-31 12693636 core:WithinOneYear 2024-03-31 12693636 bus:AllOrdinaryShares 2024-04-01 2025-03-31 12693636 bus:AllOrdinaryShares 2023-04-01 2024-03-31 12693636 core:ShareCapital 2025-03-31 12693636 core:ShareCapital 2024-03-31 12693636 core:RevaluationReserve 2025-03-31 12693636 core:RevaluationReserve 2024-03-31 12693636 core:RetainedEarningsAccumulatedLosses 2025-03-31 12693636 core:RetainedEarningsAccumulatedLosses 2024-03-31 12693636 bus:SmallEntities 2024-04-01 2025-03-31 12693636 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 12693636 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 12693636 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12693636 bus:FullAccounts 2024-04-01 2025-03-31 12693636 core:PatentsTrademarksLicencesConcessionsSimilar 2024-04-01 2025-03-31 12693636 core:PatentsTrademarksLicencesConcessionsSimilar 2025-03-31 12693636 core:PatentsTrademarksLicencesConcessionsSimilar 2024-03-31
COMPANY REGISTRATION NUMBER: 12693636
Biosynergy Holdings Limited
Filleted Unaudited Financial Statements
31 March 2025
Biosynergy Holdings Limited
Statement of Financial Position
31 March 2025
2025
2024
Note
£
£
£
Fixed assets
Intangible assets
6
230,000
270,000
Current assets
Debtors
7
6,724
20
Cash at bank and in hand
79,004
97,319
--------
--------
85,728
97,339
Creditors: amounts falling due within one year
8
81,623
66,458
--------
--------
Net current assets
4,105
30,881
---------
---------
Total assets less current liabilities
234,105
300,881
Provisions
Taxation including deferred tax
43,700
51,300
---------
---------
Net assets
190,405
249,581
---------
---------
Capital and reserves
Called up share capital
100
100
Revaluation reserve
186,300
218,700
Profit and loss account
4,005
30,781
---------
---------
Shareholders funds
190,405
249,581
---------
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
Biosynergy Holdings Limited
Statement of Financial Position (continued)
31 March 2025
These financial statements were approved by the board of directors and authorised for issue on 2 October 2025 , and are signed on behalf of the board by:
Dr Jacob
Director
Company registration number: 12693636
Biosynergy Holdings Limited
Notes to the Financial Statements
Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Ash House, Breckenwood Road, Fulbourn, Cambridge, CB21 5DQ.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Income tax
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Intangible assets
Intangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated amortisation and impairment losses. Any intangible assets carried at revalued amounts, are recorded at the fair value at the date of revaluation, as determined by reference to an active market, less any subsequent accumulated amortisation and subsequent accumulated impairment losses. Intangible assets acquired as part of a business combination are only recognised separately from goodwill when they arise from contractual or other legal rights, are separable, the expected future economic benefits are probable and the cost or value can be measured reliably.
Amortisation
Amortisation is calculated so as to write off the cost of an asset, less its estimated residual value, over the useful life of that asset as follows:
Intangible assets
-
10% straight line
If there is an indication that there has been a significant change in amortisation rate, useful life or residual value of an intangible asset, the amortisation is revised prospectively to reflect the new estimates.
Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event, it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised as a finance cost in profit or loss in the period it arises.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2024: 2 ).
5. Dividends
2025
2024
£
£
Dividends paid during the year (excluding those for which a liability existed at the end of the prior year )
100,000
99,600
---------
--------
6. Intangible assets
Royality Rights
£
Cost
At 1 April 2024 and 31 March 2025
400,000
---------
Amortisation
At 1 April 2024
130,000
Charge for the year
40,000
---------
At 31 March 2025
170,000
---------
Carrying amount
At 31 March 2025
230,000
---------
At 31 March 2024
270,000
---------
7. Debtors
2025
2024
£
£
Trade debtors
6,724
Other debtors
20
-------
----
6,724
20
-------
----
8. Creditors: amounts falling due within one year
2025
2024
£
£
Corporation tax
21,358
16,337
Social security and other taxes
2,272
Other creditors
57,993
50,121
--------
--------
81,623
66,458
--------
--------